For Immediate Release
Understanding Virtual Memory CD8+ T Cells
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, September 28, 2022—Virtual memory CD8+ T cells (TVM) are a relatively recent discovery in humans. A new review discusses what is known about them from mouse models and their cellular equivalents in humans, as described in the peer-reviewed Journal of Interferon & Cytokine Research (JICR). Click here to read the article now.
Maria Cecillia Rodriguez-Galan, from Universidad Nacional de Córdoba, and coauthors review the biology and development of innate memory (TIM) and TVM) cells in mice and humans. They describe the effector mechanisms of TIM/TVM cells, the role of TIM/TVM in the infectious process, the role of TIM/TVM in cancer, TVM cells during aging, and cytokines and TIM/TVM cells.
“The discovery of human CD8+ T cells with identical characteristics to murine TVM cells has aroused enormous interest in recent years and has posed a new challenge in trying to understand not only their role in different pathological processes, but also to discriminate what roles have been erroneously assigned to specific memory cells instead of virtual memory cells,” state the investigators. “Numerous publications are currently emerging that are clarifying more and more about the origin, functional characteristics and their role in different pathological processes, especially in infections and cancer, which will provide a new edge to understand their key role in the immune system.”
“Most immunological T cell memory is trained by exposure to antigens delivered by invading pathogens. However, a population of memory T cells emerge in the absence of obvious prior antigen exposure, termed “Virtual Memory” cells. The article by Viano and colleagues is a comprehensive review of our knowledge of this mysterious population of cells - origin, phenotype, and effector function. The authors also discuss similar populations of virtual memory CD8+ T cells in humans. The manuscript will be of particular interest to vaccinologists, immunologists, and infectious disease researchers,” says Journal of Interferon & Cytokine Research Editor-in-Chief David L. (Woody) Woodland, PhD.
About the Journal
Journal of Interferon & Cytokine Research (JICR) is an authoritative peer-reviewed journal published monthly online with open access options and in print that covers all aspects of interferons and cytokines from basic science to clinical applications. Journal of Interferon & Cytokine Research is an official journal of the International Cytokine & Interferon Society. Complete tables of content and a sample issue may be viewed on the JICR website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s more than 100 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.